Oral and anal vaccination confers full protection against enteric redmouth disease (ERM) in rainbow trout.
The effect of oral vaccines against bacterial fish diseases has been a topic for debate for decades. Recently both M-like cells and dendritic cells have been discovered in the intestine of rainbow trout. It is therefore likely that antigens reaching the intestine can be taken up and thereby induce immunity in orally vaccinated fish. The objective of this project was to investigate whether oral and anal vaccination of rainbow trout induces protection against an experimental waterborne infection with the pathogenic enterobacteria Yersinia ruckeri O1 biotype 1 the causative agent of enteric redmouth disease (ERM). Rainbow trout were orally vaccinated with AquaVac ERM Oral (MERCK Animal Health) or an experimental vaccine bacterin of Y. ruckeri O1. Both vaccines were tested with and without a booster vaccination four months post the primary vaccination. Furthermore, two groups of positive controls were included, one group receiving the experimental oral vaccine in a 50 times higher dose, and the other group receiving a single dose administered anally in order to bypass the stomach. Each group was bath challenged with 6.3 × 10(8) CFU/ml Y. ruckeri, six months post the primary vaccination. The challenge induced significant mortality in all the infected groups except for the groups vaccinated anally with a single dose or orally with the high dose of bacterin. Both of these groups had 100% survival. These results show that a low dose of Y. ruckeri bacterin induces full protection when the bacterin is administered anally. Oral vaccination also induces full protection, however, at a dose 50 times higher than if the fish were to be vaccinated anally. This indicates that much of the orally fed antigen is digested in the stomach before it reaches the second segment of the intestine where it can be taken up as immunogenic antigens and presented to lymphocytes.
Research group of Fish Diseases and Immunology, Section of Veterinary Clinical Microbiology, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Kasper Rømer
KR
Villumsen
Research group of Fish Diseases and Immunology, Section of Veterinary Clinical Microbiology, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Lukas
L
Neumann
Research group of Fish Diseases and Immunology, Section of Veterinary Clinical Microbiology, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Maki
M
Ohtani
Research group of Fish Diseases and Immunology, Section of Veterinary Clinical Microbiology, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Helene Kragelund
HK
Strøm
Research group of Fish Diseases and Immunology, Section of Veterinary Clinical Microbiology, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Martin Kristian
MK
Raida
D000284:Administration, Oral; D000285:Administration, Rectal; D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005393:Fish Diseases / Q000382:microbiology* / Q000517:prevention & control*; D060226:Head Kidney / Q000382:microbiology; D007150:Immunohistochemistry / Q000662:veterinary; D017686:Oncorhynchus mykiss; D016896:Treatment Outcome; D014611:Vaccination / Q000662:veterinary*; D015009:Yersinia Infections / Q000517:prevention & control / Q000662:veterinary*; D044124:Yersinia ruckeri / Q000187:drug effects*
D001428:Bacterial Vaccines